[HTML] sciencedirect.com

[HTML][HTML] Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼ T vaccine versus separate DTwP-HB-PRP∼ T and IPV vaccines at 12–24 …

S Mangarule, S Palkar, M Mitra, MD Ravi, R Singh… - Vaccine: X, 2022 - Elsevier
Background The combination of whole-cell pertussis (wP) antigens with established
diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b (Hib), and …
被引用次数：5 相关文章

Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼ T vaccine versus separate DTwP-HB-PRP∼ T and IPV vaccines at 12-24 months …

S Mangarule, S Palkar, M Mitra, MD Ravi, R Singh… - Vaccine: X, 2022 - europepmc.org
Background The combination of whole-cell pertussis (wP) antigens with established
diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b (Hib), and …

Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼ T vaccine versus separate DTwP-HB-PRP∼ T and IPV vaccines at 12-24 months …

S Mangarule, S Palkar, M Mitra, MD Ravi… - Vaccine …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The combination of whole-cell pertussis (wP) antigens with established
diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b (Hib), and …
[HTML] nih.gov

[HTML][HTML] Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼ T vaccine versus separate DTwP-HB-PRP∼ T and IPV vaccines at 12–24 …

S Mangarule, S Palkar, M Mitra, MD Ravi, R Singh… - Vaccine: X, 2022 - ncbi.nlm.nih.gov
Background The combination of whole-cell pertussis (wP) antigens with established
diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b (Hib), and …